170 related articles for article (PubMed ID: 33050628)
1. E-Cadherin (
Corso G; Bonanni B
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050628
[TBL] [Abstract][Full Text] [Related]
2. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
[TBL] [Abstract][Full Text] [Related]
3. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review.
Corso G; Montagna G; Figueiredo J; La Vecchia C; Fumagalli Romario U; Fernandes MS; Seixas S; Roviello F; Trovato C; Guerini-Rocco E; Fusco N; Pravettoni G; Petrocchi S; Rotili A; Massari G; Magnoni F; De Lorenzi F; Bottoni M; Galimberti V; Sanches JM; Calvello M; Seruca R; Bonanni B
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560361
[TBL] [Abstract][Full Text] [Related]
4. Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defect.
Schwarz A
Langenbecks Arch Surg; 2003 Mar; 388(1):27-32. PubMed ID: 12690477
[TBL] [Abstract][Full Text] [Related]
5. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.
Shenoy S
Cancer Manag Res; 2019; 11():10477-10486. PubMed ID: 31853199
[TBL] [Abstract][Full Text] [Related]
6. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
[TBL] [Abstract][Full Text] [Related]
7. Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer: an analysis in the District of Urbino, Region Marche, Central Italy.
Graziano F; Ruzzo AM; Bearzi I; Testa E; Lai V; Magnani M
Tumori; 2003; 89(3):255-8. PubMed ID: 12908778
[TBL] [Abstract][Full Text] [Related]
8. Hereditary diffuse gastric cancer - pathophysiology and clinical management.
Pinheiro H; Oliveira C; Seruca R; Carneiro F
Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1055-68. PubMed ID: 25439071
[TBL] [Abstract][Full Text] [Related]
9. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
11. Germline E-cadherin mutations in familial lobular breast cancer.
Masciari S; Larsson N; Senz J; Boyd N; Kaurah P; Kandel MJ; Harris LN; Pinheiro HC; Troussard A; Miron P; Tung N; Oliveira C; Collins L; Schnitt S; Garber JE; Huntsman D
J Med Genet; 2007 Nov; 44(11):726-31. PubMed ID: 17660459
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Clinical Characteristics of Unselected Korean Gastric Cancer Patients with a Germline
Shin S; Kim Y; Lee JK; Lee KA
J Cancer; 2020; 11(1):208-212. PubMed ID: 31892987
[No Abstract] [Full Text] [Related]
14. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
[TBL] [Abstract][Full Text] [Related]
15. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.
Luo W; Fedda F; Lynch P; Tan D
Front Pharmacol; 2018; 9():1421. PubMed ID: 30568591
[TBL] [Abstract][Full Text] [Related]
16. Genetic screening for familial gastric cancer.
Oliveira C; Suriano G; Ferreira P; Canedo P; Kaurah P; Mateus R; Ferreira A; Ferreira AC; Oliveira MJ; Figueiredo C; Carneiro F; Keller G; Huntsman D; Machado JC; Seruca R
Hered Cancer Clin Pract; 2004 May; 2(2):51-64. PubMed ID: 20233471
[TBL] [Abstract][Full Text] [Related]
17. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea.
Kim HC; Wheeler JM; Kim JC; Ilyas M; Beck NE; Kim BS; Park KC; Bodmer WF
Gut; 2000 Aug; 47(2):262-7. PubMed ID: 10896919
[TBL] [Abstract][Full Text] [Related]
18. Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk.
Li D; Lo W; Rudloff U
Clin Transl Med; 2018 Feb; 7(1):7. PubMed ID: 29468433
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing by cancer site: stomach.
Chun N; Ford JM
Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
